{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:42:02Z","timestamp":1794433322927,"version":"4.9.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined 807 productive IGHV-IGHD-IGHJ gene rearrangements from mantle cell lymphoma (MCL) cases, by far the largest series to date. The IGHV gene repertoire was remarkably biased, with IGHV3-21, IGHV4-34, IGHV1-8, and IGHV3-23 accounting for 46.3% of the cohort. Eighty-four of 807 (10.4%) cases, mainly using the IGHV3-21 and IGHV4-34 genes, were found to bear stereotyped heavy complementarity-determining region 3 (VH CDR3) sequences and were placed in 38 clusters. Notably, the MCL stereotypes were distinct from those reported for chronic lymphocytic leukemia. Based on somatic hypermutation (SHM) status, 238\/807 sequences (29.5%) carried IGHV genes with 100% germ line identity; the remainder (569\/807; 70.5%) exhibited different SHM impact, ranging from minimal (in most cases) to pronounced. Shared replacement mutations across the IGHV gene were identified for certain subgroups, especially those using IGHV3-21, IGHV1-8, and IGHV3-23. Comparison with other entities, in particular CLL, revealed that several of these mutations were \u201cMCL-biased.\u201d In conclusion, MCL is characterized by a highly restricted immunoglobulin gene repertoire with stereotyped VH CDR3s and very precise SHM targeting, strongly implying a role for antigen-driven selection of the clonogenic progenitors. Hence, an antigen-driven origin of MCL could be envisaged, at least for subsets of cases.<\/jats:p>","DOI":"10.1182\/blood-2011-03-343434","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:13:27Z","timestamp":1311725607000},"page":"3088-3095","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":156,"title":["Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases"],"prefix":"10.1182","volume":"118","author":[{"given":"Anastasia","family":"Hadzidimitriou","sequence":"first","affiliation":[{"name":"Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Agathangelidis","sequence":"additional","affiliation":[{"name":"Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;"},{"name":"Department of Hematology and Hematopoietic Cell Transplantation (HCT) Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;"},{"name":"School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Darzentas","sequence":"additional","affiliation":[{"name":"Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Delfau-Larue","sequence":"additional","affiliation":[{"name":"Hopital Henri Mondor, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), and Universite Paris\u2013XII Val de Marnes, Creteil, France;"},{"name":"Department of Immunology, Hopital Henri Mondor AP-HP, and Universite Paris\u2013XII Val de Marne, Creteil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Bredo","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Navarro","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Clinic, and Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Dagklis","sequence":"additional","affiliation":[{"name":"Laboratory of B Cell Neoplasia and Unit of Lymphoid Malignancies, Universit\u00e0 Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rombout","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheira","family":"Beldjord","sequence":"additional","affiliation":[{"name":"H\u00f4pital Necker AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Dreyling","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Munich\u2013Campus Grosshadern, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation (HCT) Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsaftaris","sequence":"additional","affiliation":[{"name":"Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Mavragani-Tsipidou","sequence":"additional","affiliation":[{"name":"School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Wuerzburg, Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Pathology Unit and Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Groenen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"Laboratory of B Cell Neoplasia and Unit of Lymphoid Malignancies, Universit\u00e0 Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sander","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Evangelismos Hospital, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Clinic, and Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Geisler","sequence":"additional","affiliation":[{"name":"Department of Haematology, Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Davi","sequence":"additional","affiliation":[{"name":"Service d'Hematologie Biologique, AP-HP, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;"},{"name":"Department of Hematology and Hematopoietic Cell Transplantation (HCT) Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111806345183700_B1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/asheducation-2009.1.542","article-title":"Current treatment standards and emerging strategies in mantle cell lymphoma.","author":"Dreyling","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2019111806345183700_B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.","volume":"117","author":"P\u00e9rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111806345183700_B3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"2019111806345183700_B4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2019111806345183700_B5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"key":"2019111806345183700_B6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/asheducation-2007.1.270","article-title":"Mantle cell lymphoma: identifying novel molecular targets in growth and survival pathways.","author":"O'Connor","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111806345183700_B7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","article-title":"The occurrence and significance of V gene mutations in B cell-derived human malignancy.","volume":"83","author":"Stevenson","year":"2001","journal-title":"Adv Cancer Res"},{"issue":"4","key":"2019111806345183700_B8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis.","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019111806345183700_B9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"issue":"1405","key":"2019111806345183700_B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1098\/rstb.2000.0751","article-title":"Somatic hypermutation and B-cell lymphoma.","volume":"356","author":"Dunn-Walters","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"2019111806345183700_B11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/leu.2009.186","article-title":"A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence.","volume":"24","author":"Darzentas","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"2019111806345183700_B12","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.","volume":"101","author":"Camacho","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2019111806345183700_B13","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111806345183700_B14","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"3","key":"2019111806345183700_B15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2008.199","article-title":"Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity.","volume":"22","author":"Schraders","year":"2009","journal-title":"Mod Pathol"},{"issue":"4","key":"2019111806345183700_B16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma.","volume":"68","author":"Thors\u00e9lius","year":"2002","journal-title":"Eur J Haematol"},{"issue":"10","key":"2019111806345183700_B17","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","article-title":"Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.","volume":"101","author":"Walsh","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111806345183700_B18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/10428190801947559","article-title":"Molecular genetic characterization reveals new subsets of mantle cell lymphoma.","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2019111806345183700_B19","volume-title":"WHO Classification of Tumors of Haemopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"6","key":"2019111806345183700_B20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2019111806345183700_B21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1073\/pnas.92.7.2529","article-title":"Human autoantibody recognition of DNA.","volume":"92","author":"Barbas","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111806345183700_B22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1191\/0961203302lu302rr","article-title":"Systematic analysis of sequences of anti-DNA antibodies\u2014relevance to theories of origin and pathogenicity.","volume":"11","author":"Rahman","year":"2002","journal-title":"Lupus"},{"issue":"12","key":"2019111806345183700_B23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2019111806345183700_B24","doi-asserted-by":"crossref","first-page":"D781","DOI":"10.1093\/nar\/gkj088","article-title":"IMGT\/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences.","volume":"34","author":"Giudicelli","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"2019111806345183700_B25","doi-asserted-by":"crossref","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","article-title":"IMGT, the international ImMunoGeneTics information system.","volume":"37","author":"Lefranc","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2019111806345183700_B26","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis.","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2019111806345183700_B27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.","volume":"27","author":"Lefranc","year":"2003","journal-title":"Dev Comp Immunol"},{"key":"2019111806345183700_B28","doi-asserted-by":"crossref","first-page":"i379","DOI":"10.1093\/bioinformatics\/bth945","article-title":"IMGT\/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs.","volume":"20","author":"Yousfi Monod","year":"2004","journal-title":"Bioinformatics"},{"issue":"1","key":"2019111806345183700_B29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/prot.340170108","article-title":"Performance evaluation of amino acid substitution matrices.","volume":"17","author":"Henikoff","year":"1993","journal-title":"Proteins"},{"issue":"1","key":"2019111806345183700_B30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jmr.647","article-title":"IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties.","volume":"17","author":"Pommi\u00e9","year":"2004","journal-title":"J Mol Recognit"},{"issue":"7","key":"2019111806345183700_B31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2010-03-275859","article-title":"High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.","volume":"116","author":"Wu","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2019111806345183700_B32","first-page":"25","article-title":"The composition of the B cell receptor repertoire in 7428 cases of chronic lymphocytic leukemia: one third stereotyped, two thirds heterogeneous\u2014what does this mean? [abstract]","volume":"116","author":"Agathangelidis","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2019111806345183700_B33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V116.21.634.634","article-title":"More than 30% of patients with splenic marginal zone lymphoma express distinctive antigen receptors utilizing a single immunoglobulin variable gene: implications for the origin and selection of the neoplastic cells [abstract].","volume":"116","author":"Bikos","year":"2010","journal-title":"Blood"},{"key":"2019111806345183700_B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation.","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2019111806345183700_B35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jmr.679","article-title":"Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.","volume":"17","author":"Barrios","year":"2004","journal-title":"J Mol Recognit"},{"issue":"1","key":"2019111806345183700_B36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":"Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.","volume":"13","author":"Xu","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"2019111806345183700_B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2001.01380.x","article-title":"Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.","volume":"123","author":"Mageed","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2019111806345183700_B38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations.","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111806345183700_B39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"issue":"13","key":"2019111806345183700_B40","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2019111806345183700_B41","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111806345183700_B42","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2006-07-037150","article-title":"A novel human B cell subpopulation representing the initial germinal center population to express AID.","volume":"109","author":"Kolar","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2019111806345183700_B43","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells.","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111806345183700_B44","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.0803391","article-title":"Identification and characterization of a human CD5+ pre-naive B cell population.","volume":"182","author":"Lee","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"2019111806345183700_B45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.180.2.800","article-title":"CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.","volume":"180","author":"Capolunghi","year":"2008","journal-title":"J Immunol"},{"issue":"21","key":"2019111806345183700_B46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood.V116.21.964.964","article-title":"The Btk inhibitor, PCI-32765, induces durable responses with minimal toxicity in patients with relapsed\/refractory B-cell malignancies: results from a phase I study [abstract].","volume":"116","author":"Fowler","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2019111806345183700_B47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V116.21.55.55","article-title":"CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110\u03b4, demonstrates clinical activity and pharmacodynamic effects in patients with relapsed or refractory chronic lymphocytic leukemia [abstract].","volume":"116","author":"Furman","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/11\/3088\/1341420\/zh803711003088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/11\/3088\/1341420\/zh803711003088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T08:18:42Z","timestamp":1712650722000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/11\/3088\/28461\/Is-there-a-role-for-antigen-selection-in-mantle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-03-343434","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}